BIO

Bio-Rad Laboratories, Inc.

Technology
304.36 +3.38 +1.12% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 8.20B
EV 7.62B
Shares Out 26.96M
Revenue (ttm) 2.59B
Net Income 168.80M
Beta —
P/E —
Forward P/E —
EPS (ttm) $6.01
P/S 3.17
P/B 1.20
P/FCF 22.97
P/C 16.08
EV/Sales 2.94
EV/EBITDA 34.16
ROA 1.72%
ROE 2.5%
ROIC 0.56%
Gross Margin 51.87%
Oper. Margin 2.22%
Profit Margin 6.52%
Debt/Eq 0.14
LT Debt/Cap 10.49%
Quick Ratio 2.17
Current Ratio 3.21
Book/sh 254.15
Cash/sh 18.81
Div Yield —
Div TTM —
Payout Ratio —
SMA20 3.92%
SMA50 6.05%
SMA200 3.24%
Volume 287,200
Avg Volume 354.67K
Rel Volume 0.81
Perf Week 2.28%
Perf Month 7.76%
Perf Quarter 0.34%
Perf Half Y -2.69%
Perf YTD 0.45%
Perf Year 23.52%
Perf 3Y -23.57%
Perf 5Y -54.47%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems,…

Name
Bio-Rad Laboratories, Inc.
Industry
Technology
CEO
Norman Schwartz · Chief Executive Officer and Chairman of the Board
Employees
7,450 as of 2025-12-31
IPO Date
2011-06-15
Phone
(510) 724-7000
Address
1000 Alfred Nobel Drive, Hercules, CA 94547
Website
www.bio-rad.com

Key Executives

Name Title FY Pay
Arnold A. Pinkston Director —
Melinda Litherland Director —
Gregory K. Hinckley Director —
Jeffrey L. Edwards Director —
Norman Schwartz Chief Executive Officer and Chairman of the Board —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.